Search

Your search keyword '"Naoya Takayama"' showing total 92 results

Search Constraints

Start Over You searched for: Author "Naoya Takayama" Remove constraint Author: "Naoya Takayama"
92 results on '"Naoya Takayama"'

Search Results

1. iPSC-derived megakaryocytes and platelets accelerate wound healing and angiogenesis

2. Retrotransposons in Werner syndrome-derived macrophages trigger type I interferon-dependent inflammation in an atherosclerosis model

Catalog

Books, media, physical & digital resources

3. Defective flow space limits the scaling up of turbulence bioreactors for platelet generation

4. Osteogenic effects and safety of human induced pluripotent stem cell-derived megakaryocytes and platelets produced on a clinical scale

5. A let-7 microRNA-RALB axis links the immune properties of iPSC-derived megakaryocytes with platelet producibility

6. Combined effect of DBM, PRP, and bone marrow fluid on bone union in a rat posterolateral fusion model

7. Objective Weight Interval Estimation Using Adversarial Inverse Reinforcement Learning

8. Epigenetic traits inscribed in chromatin accessibility in aged hematopoietic stem cells

9. The Effect of Megakaryocytes and Platelets Derived from Human-Induced Pluripotent Stem Cells on Bone Formation

10. Generation of disease-specific and CRISPR/Cas9-mediated gene-corrected iPS cells from a patient with adult progeria Werner syndrome

11. Suppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells

12. Acacia Polyphenol Ameliorates Atopic Dermatitis in Trimellitic Anhydride-Induced Model Mice via Changes in the Gut Microbiota

13. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib Induces Dry Skin via Decreased in Aquaporin-3 Expression

14. Profiling of microRNA in human and mouse ES and iPS cells reveals overlapping but distinct microRNA expression patterns.

15. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.

17. UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease

18. Silencing of p53 and CDKN1A establishes sustainable immortalized megakaryocyte progenitor cells from human iPSCs

19. A primary hierarchically organized patient-derived model enables in depth interrogation of stemness driven by the coding and non-coding genome

20. Retrotransposons in Werner syndrome-derived macrophages trigger type I interferon-dependent inflammation in an atherosclerosis model

21. The chromatin-binding protein Phf6 restricts the self-renewal of hematopoietic stem cells

22. Stem cell therapy for skin regeneration using mesenchymal stem cells derived from the progeroid Werner syndrome-specific iPS cells

23. Epigenetic traits inscribed in chromatin accessibility in aged hematopoietic stem cells

24. Generation of disease-specific and CRISPR/Cas9-mediated gene-corrected iPS cells from a patient with adult progeria Werner syndrome

25. Accessibility Over Transposable Elements Reveals Genetic Determinants of Stemness Properties in Normal and Leukemic Hematopoiesis

26. The Cxxc1 subunit of the Trithorax complex directs epigenetic licensing of CD4+ T cell differentiation

27. Fibroblasts from different body parts exhibit distinct phenotypes in adult progeria Werner syndrome

29. The Transition from Quiescent to Activated States in Human Hematopoietic Stem Cells Is Governed by Dynamic 3D Genome Reorganization

30. Author Correction: A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies

31. MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin

32. IL-1α induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs

33. Characterization of mesenchymal progenitor cells in the crown and root pulp of primary teeth

34. Generation of induced pluripotent stem cells derived from primary and secondary myelofibrosis patient samples

35. Multicolor Staining of Globin Subtypes Reveals Impaired Globin Switching During Erythropoiesis in Human Pluripotent Stem Cells

36. Expandable Megakaryocyte Cell Lines Enable Clinically Applicable Generation of Platelets from Human Induced Pluripotent Stem Cells

37. Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling

38. Mutant IDH1 downregulates ATM and alters DNA repair and sensitivity to DNA damage independent of TET2

39. Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells

40. Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples

41. Pluripotent stem cells reveal the developmental biology of human megakaryocytes and provide a source of platelets for clinical application

42. PKA/CREB Signaling Triggers Initiation of Endothelial and Hematopoietic Cell Differentiation via Etv2 Induction

43. A cluster of enhancer modules directs differential MYC expression along the normal and leukemic haematopoietic stem cell hierarchies

44. Heterozygous ITGA2B R995W mutation inducing constitutive activation of the αIIbβ3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia

45. Sphingolipid Perturbation Activates Proteostasis Programs to Govern Human Hematopoietic Stem Cell Self-Renewal

46. Anagrelide Inhibits Proliferation and Platelet Generation in Immortalized Megakaryocyte Progenitor Cell Lines Established from Human Induced Pluripotent Stem Cells

47. Identification of Gene Regulatory Networks Governing Stemness Properties of Human HSC and LSC

48. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells

49. Author Correction: A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies

50. Lnk regulates integrin αIIbβ3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo